|
1
|
Kuru D, Tarkan-Argüden Y, Ar MC, Çırakoğlu
A, Öngören Ş, Yılmaz Ş, Eşkazan AE, Deviren A, Soysal T,
Hacıhanefioğlu S and Ülkü B: Variant Philadelphia translocations
with different breakpoints in six chronic myeloid leukemia
patients. Turk J Hematol. 28:186–192. 2001. View Article : Google Scholar
|
|
2
|
Aliano S, Cirmena G, Fugazza G, Bruzzone
R, Palermo C and Sessarego M: Standard and variant Philadelphia
translocation in a CML patient with different sensitivity to
imatinib therapy. Leuk Res Rep. 2:75–78. 2013.PubMed/NCBI
|
|
3
|
Quintás-Cardama A and Cortes JE: Chronic
myeloid leukemia: Diagnosis and treatment. Mayo Clin Proc.
81:973–988. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aguayo A, García-Álvarez E,
Cázarez-Ordónez Y, Crespo-Solís E, Martínez-Baños D,
Guadarrama-Beltrán E, Cervera-Ceballos EE and López-Karpovicth X:
Chronic myeloid leukemia: A clinicoepidemiologic and therapeutic
description of a single institution in México City. Clinical
Leukemia. 2:261–266. 2008. View Article : Google Scholar
|
|
5
|
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar
S, Kim DW, Kweon IY, O'Neil WM, Saikia TK and Wang J: Chronic
myeloid leukemia in Asia. Int J Hematol. 89:14–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sawyers CL: Chronic myeloid leukemia. N
Engl J Med. 340:1330–1340. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Achkar W, Wafa A and Liehr T: A new
t(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-positive
chronic myeloid leukemia case. Oncol Lett. 5:605–608.
2013.PubMed/NCBI
|
|
8
|
Sessarego M, Fugazza G, Bruzzone R,
Ballestrero A, Miglino M and Bacigalupo A: Complex chromosome
rearrangements may locate the bcr/abl fusion gene sites other than
22q11. Haematologica. 85:35–39. 2000.PubMed/NCBI
|
|
9
|
O'Brien SG, Meinhardt P, Bond E, Beck J,
Peng B, Dutreix C, Mehring G, Milosavljev S, Huber C, Capdeville R
and Fischer T: Effects of imatinib mesylate (STI571, Glivec) on the
pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate,
in patients with chronic myeloid leukaemia. Br J Cancer.
89:1855–1859. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Todaro J, Ferreira E, Hamerschlak N, Simon
SD, Kutner JM, Pietrocola M and Borovik CL: Imatinib improves
survival of CML patients in accelerated phase: A 48-month
follow-up. Einstein. 4:16–21. 2006.
|
|
11
|
Cohen MH, Williams G, Johnson JR, Duan J,
Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, et al:
Approval summary for imatinib mesylate capsules in the treatment of
chronic myelogenous leukemia. Clin Cancer Res. 8:935–942.
2002.PubMed/NCBI
|
|
12
|
Cohen MS, Hussain HB and Moley JF:
Inhibition of medullary thyroid carcinoma cell proliferation and
RET phosphorylation by tyrosine kinase inhibitors. Surgery.
132:960–966. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simons A, Shaffer LG and Hastings RJ:
Cytogenetic nomenclature: Changes in the ISCN 2013 compared to the
2009 edition. Cytogenet Genome Res. 141:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Froncillo MC, Maffei L, Cantonetti M, Del
Poeta G, Lentini R, Bruno A, Masi M, Tribalto M and Amadori S: FISH
analysis for CML monitoring? Ann Hematol. 73:113–119. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buño I, Wyatt WA, Zinsmeister AR,
Dietz-Band J, Silver RT and Dewald GW: A special fluorescent in
situ hybridization technique to study peripheral blood and assess
the effectiveness of interferon therapy in chronic myeloid
leukemia. Blood. 92:2315–2321. 1998.PubMed/NCBI
|
|
17
|
La Starza R, Testoni N, Lafage-Pochitaloff
M, Ruggeri D, Ottaviani E, Perla G, Martelli MF, Marynen P and
Mecucci C: Complex variant Philadelphia translocations involving
the short arm of chromosome 6 in chronic myeloid leukemia.
Haematologica. 87:143–147. 2002.PubMed/NCBI
|
|
18
|
Morel F, Herry A, Le Bris MJ, Morice P,
Bouquard P, Abgrall JF, Berthou C and De Braekeleer M: Contribution
of fluorescence in situ hybridization analyses to the
characterization of masked and complex Philadelphia chromosome
translocations in chronic myelocytic leukemia. Cancer Genet
Cytogenet. 147:115–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Emberger W, Behmel A, Tschernigg M,
Seewann HL, Petek E, Kroisel PM and Wagner K: Chronic myeloid
leukemia with a rare variant Philadelphia translocation:
t(9;10;22)(q34;q22;q11). Cancer Genet Cytogenet. 129:76–79. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reddy KS and Sulcova V: A FISH study of
variant Philadelphia rearrangements. Cancer Genet Cytogenet.
118:121–131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sessarego M, Fugazza G, Canepa L,
Bacigalupo A, Bruzzone R and Patrone F: Fluorescence in situ
hybridization provides evidence for two step rearrangement in a
masked Ph chromosome formation. Leuk Res. 19:921–925. 1995.
View Article : Google Scholar : PubMed/NCBI
|
